Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - CTI BIOPHARMA CORPFinancial_Report.xls
EX-32 - EX-32 - CTI BIOPHARMA CORPctic-ex32_2014123111.htm
EX-12.1 - EX-12.1 - CTI BIOPHARMA CORPctic-ex121_201412316.htm
EX-23.1 - EX-23.1 - CTI BIOPHARMA CORPctic-ex231_201412318.htm
EX-31.1 - EX-31.1 - CTI BIOPHARMA CORPctic-ex311_2014123110.htm
EX-10.6 - EX-10.6 - CTI BIOPHARMA CORPctic-ex106_20141231464.htm
EX-10.4 - EX-10.4 - CTI BIOPHARMA CORPctic-ex104_20141231463.htm
EX-10.14 - EX-10.14 - CTI BIOPHARMA CORPctic-ex1014_201412311331.htm
EX-10.16 - EX-10.16 - CTI BIOPHARMA CORPctic-ex1016_201412312020.htm
EX-10.48 - EX-10.48 - CTI BIOPHARMA CORPctic-ex1048_201412311721.htm
EX-10.15 - EX-10.15 - CTI BIOPHARMA CORPctic-ex1015_201412311332.htm
10-K - 10-K - CTI BIOPHARMA CORPctic-10k_20141231.htm
EX-31.2 - EX-31.2 - CTI BIOPHARMA CORPctic-ex312_201412317.htm

Exhibit 21.1

Subsidiaries of CTI BioPharma Corp.

Aequus Biopharma, Inc., a Washington corporation, Systems Medicine, LLC, a Delaware limited liability company, and CTI Life Sciences Ltd., a U.K. limited company.

The above paragraph includes all subsidiaries of CTI BioPharma Corp.